SDG, Inc. is a privately held developer of bio-nanotechnologies for use in drug delivery systems and in consumer product applications. The Company's patented systems have been used in the creation and development of novel oral delivery systems for insulin, interferon and other protein-based therapies, cell-receptor targeting of a wide variety of large and small molecule drugs and diagnostics, and consumer products ranging from hair conditioners and styling agents to skin-adhering insect repellents and sunscreens. These systems are ideally suited for use as cell receptor targeted vehicles in personalized medicine strategies for cancer. SDG's technologies have been tested in more than four hundred human subjects and have been shown to be both safe and efficacious in various disease categories, including diabetes and hepatitis.
View Top Employees from SDG, Inc.Website | http://www.sdgpharma.com |
Revenue | $13.6 million |
Employees | 3 (2 on RocketReach) |
Address | 10000 Cedar Ave, Cleveland, Ohio 44106, US |
Phone | (216) 444-7110 |
Fax | (216) 274-9529 |
Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
Web Rank | 8 Million |
Keywords | Sdg Inc |
Competitors | Axcellerate Pharma LLC, Immunohelix, PharmOptima™, Polaris Pharmaceuticals, Velesco Pharmaceutical Services |
SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 325412 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies |
Looking for a particular SDG, Inc. employee's phone or email?
The SDG, Inc. annual revenue was $13.6 million in 2024.
2 people are employed at SDG, Inc..
SDG, Inc. is based in Cleveland, Ohio.
The NAICS codes for SDG, Inc. are [325, 325412, 32, 32541, 54, 3254, 541].
The SIC codes for SDG, Inc. are [28, 283, 2834].